XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2019   10,899,210    
Balance at beginning of period at Dec. 31, 2019 $ 212,508 $ 64,073 $ 144,839 $ 3,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 13,064   13,064  
Net unrealized gain on securities available for sale, net of tax 3,443     3,443
Net unrealized gain on securities transferred from available for sale to held to maturity, net of amortization 36     36
Net unrealized gain (loss) on cash flow hedging derivative instruments (6,284)     (6,284)
Comprehensive income (loss) 10,259   13,064 (2,805)
Cash dividend declared (6,666)   (6,666)  
Equity compensation expense 312 $ 312    
Payment to repurchase common stock (in shares)   (5,297)    
Payment to repurchase common stock (154)   (154)  
Issuance of restricted stock (in shares)   25,845    
Proceeds from sale of common stock (in shares)   13,670    
Proceeds from sale of common stock $ 325 $ 325    
Ending balance (in shares) at Jun. 30, 2020 10,933,428 10,933,428    
Balance at end of period at Jun. 30, 2020 $ 216,584 $ 64,710 151,083 791
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 6,569      
Net unrealized gain on securities available for sale, net of tax (790)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of amortization 28      
Net unrealized gain (loss) on cash flow hedging derivative instruments (1,414)      
Comprehensive income (loss) $ 4,393      
Ending balance (in shares) at Jun. 30, 2020 10,933,428 10,933,428    
Balance at end of period at Jun. 30, 2020 $ 216,584 $ 64,710 151,083 791
Beginning balance (in shares) at Dec. 31, 2020 10,950,289 10,950,289    
Balance at beginning of period at Dec. 31, 2020 $ 223,726 $ 65,395 158,359 (28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 17,709   17,709  
Net unrealized gain on securities available for sale, net of tax (3,819)     (3,819)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of amortization 20     20
Net unrealized gain (loss) on cash flow hedging derivative instruments 2,849     2,849
Comprehensive income (loss) 16,759   17,709 (950)
Cash dividend declared (6,920)   (6,920)  
Equity compensation expense 490 $ 490    
Payment to repurchase common stock (in shares)   (9,561)    
Payment to repurchase common stock (240)   (240)  
Issuance of restricted stock (in shares)   34,689    
Proceeds from sale of common stock (in shares)   12,263    
Proceeds from sale of common stock $ 340 $ 340    
Ending balance (in shares) at Jun. 30, 2021 10,987,680 10,987,680    
Balance at end of period at Jun. 30, 2021 $ 234,155 $ 66,225 168,908 (978)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 8,787      
Net unrealized gain on securities available for sale, net of tax 971      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of amortization 11      
Net unrealized gain (loss) on cash flow hedging derivative instruments (620)      
Comprehensive income (loss) $ 9,149      
Ending balance (in shares) at Jun. 30, 2021 10,987,680 10,987,680    
Balance at end of period at Jun. 30, 2021 $ 234,155 $ 66,225 $ 168,908 $ (978)